Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study
Titel:
Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study
Auteur:
Fu, Weijun Bang, Soo-Mee Huang, Honghui Kim, Kihyun Li, Wei An, Gang Lee, Je-Jung Cai, Zhen Jin, Jie Wang, Yafei Lin, Tung-Liang Chim, Chor Sang Qi, Ming Wang, Jianping Lu, Xiaolin Song, Yang Jia, Bin Yang, Xue Liu, Wenyu Zhou, Tianyuan Yin, Lu Li, Yunan Zhang, Renyi Hou, Jian Wang, Jianxiang